Skip to main content
Top
Published in:

Open Access 20-12-2024 | Congenital Valvular Heart Disease | Case Report

Recurrent strokes after transcatheter aortic valve replacement in an elderly patient with severe bicuspid aortic valve stenosis: a case report

Authors: Xuyang Meng, Xiang Wang, Chenguang Yang, Huiping Zhang, You Zhong, Fang Wang

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Background

Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients with symptomatic severe aortic valve stenosis (AS). Recently, its use has also been extended to low-risk patients, resulting in its increasing utilization in patients with bicuspid aortic valve (BAV). But as a serious post-TAVR complication, ischemic stroke was associated with a nearly 6‐fold increased 30‐day mortality. BAV presents unique challenges for post-TAVR antithrombotic therapy due to its distinct valvular anatomy.

Case presentation

We present a case of a 72-year-old female who presented with angina pectoris symptoms and was found to have severe BAV stenosis (Type 0). According to the patient’s age, obvious symptom and willingness herself, TAVR was successful performed with deployment of a 23 mm Venus-A Plus valve (Venus Medtech, Hangzhou, China). A post-procedure echocardiogram confirmed the appropriate placement of the bioprosthetic valve with minor paravalvular regurgitation. Six months after TAVR, this patient experienced multiple strokes, presenting a significant challenge for clinicians.

Conclusions

This case underscores the serious complications that can occur post-TAVR and highlights the need for improved strategies to prevent early strokes.
Literature
1.
go back to reference Leon MB, Smith CR, Mack MJ, et al. PARTNER 2 investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRefPubMed Leon MB, Smith CR, Mack MJ, et al. PARTNER 2 investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRefPubMed
2.
go back to reference Leon MB, Smith CR, Mack M, et al. PARTNER trial investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.CrossRefPubMed Leon MB, Smith CR, Mack M, et al. PARTNER trial investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.CrossRefPubMed
3.
go back to reference Smith CR, Leon MB, Mack MJ, et al. PARTNER trial investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefPubMed Smith CR, Leon MB, Mack MJ, et al. PARTNER trial investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefPubMed
4.
go back to reference Mack MJ, Leon MB, Thourani VH, et al. PARTNER 3 investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705.CrossRefPubMed Mack MJ, Leon MB, Thourani VH, et al. PARTNER 3 investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705.CrossRefPubMed
5.
go back to reference Vincent F, Ternacle J, Van Belle E, et al. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. Circulation. 2021;143(10):1043–61.CrossRefPubMed Vincent F, Ternacle J, Van Belle E, et al. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. Circulation. 2021;143(10):1043–61.CrossRefPubMed
6.
go back to reference Kapadia S, Agarwal S, Miller DC, et al. Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER Trial (Placement of aortic transcatheter valves). Circ Cardiovasc Interv. 2016;9(9):e002981.CrossRefPubMed Kapadia S, Agarwal S, Miller DC, et al. Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER Trial (Placement of aortic transcatheter valves). Circ Cardiovasc Interv. 2016;9(9):e002981.CrossRefPubMed
7.
go back to reference Kleiman NS, Maini BJ, Reardon MJ, et al. CoreValve investigators. Neurological events following transcatheter aortic valve replacement and their predictors: a Report from the CoreValve trials. Circ Cardiovasc Interv. 2016;9(9):e003551.CrossRefPubMed Kleiman NS, Maini BJ, Reardon MJ, et al. CoreValve investigators. Neurological events following transcatheter aortic valve replacement and their predictors: a Report from the CoreValve trials. Circ Cardiovasc Interv. 2016;9(9):e003551.CrossRefPubMed
8.
go back to reference Montalto C, Sticchi A, Crimi G, et al. Outcomes after transcatheter aortic valve replacement in Bicuspid Versus Tricuspid anatomy: a systematic review and Meta-analysis. JACC Cardiovasc Interv. 2021;14(19):2144–55.CrossRefPubMed Montalto C, Sticchi A, Crimi G, et al. Outcomes after transcatheter aortic valve replacement in Bicuspid Versus Tricuspid anatomy: a systematic review and Meta-analysis. JACC Cardiovasc Interv. 2021;14(19):2144–55.CrossRefPubMed
9.
go back to reference Zhang J, Li X, Tian R, et al. Outcomes of cerebral Embolic Protection for Bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement. J Am Heart Assoc. 2023;12(12):e028890.CrossRefPubMedPubMedCentral Zhang J, Li X, Tian R, et al. Outcomes of cerebral Embolic Protection for Bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement. J Am Heart Assoc. 2023;12(12):e028890.CrossRefPubMedPubMedCentral
10.
go back to reference Makkar RR, Yoon SH, Leon MB, et al. Association between Transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke. JAMA. 2019;321(22):2193–202.CrossRefPubMedPubMedCentral Makkar RR, Yoon SH, Leon MB, et al. Association between Transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke. JAMA. 2019;321(22):2193–202.CrossRefPubMedPubMedCentral
11.
go back to reference Huded CP, Tuzcu EM, Krishnaswamy A, et al. Association between Transcatheter Aortic Valve Replacement and early postprocedural stroke. JAMA. 2019;321(23):2306–15.CrossRefPubMedPubMedCentral Huded CP, Tuzcu EM, Krishnaswamy A, et al. Association between Transcatheter Aortic Valve Replacement and early postprocedural stroke. JAMA. 2019;321(23):2306–15.CrossRefPubMedPubMedCentral
12.
go back to reference Nuyens P, De Backer O, Sathananthan J, et al. TAVR in bicuspid aortic stenosis: current evidence and proposal for a Randomized Controlled Trial Design. JACC Cardiovasc Interv. 2023;16(13):1682–7.CrossRefPubMed Nuyens P, De Backer O, Sathananthan J, et al. TAVR in bicuspid aortic stenosis: current evidence and proposal for a Randomized Controlled Trial Design. JACC Cardiovasc Interv. 2023;16(13):1682–7.CrossRefPubMed
13.
go back to reference Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111(7):920–5.CrossRefPubMed Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111(7):920–5.CrossRefPubMed
14.
go back to reference Reardon MJ, Van Mieghem NM, Popma JJ, et al. SURTAVI investigators. Surgical or Transcatheter aortic-valve replacement in Intermediate-Risk patients. N Engl J Med. 2017;376(14):1321–31.CrossRefPubMed Reardon MJ, Van Mieghem NM, Popma JJ, et al. SURTAVI investigators. Surgical or Transcatheter aortic-valve replacement in Intermediate-Risk patients. N Engl J Med. 2017;376(14):1321–31.CrossRefPubMed
15.
go back to reference VARC-3 WRITING COMMITTEE, Généreux P, Piazza N, Alu MC, et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021;42(19):1825–57.CrossRef VARC-3 WRITING COMMITTEE, Généreux P, Piazza N, Alu MC, et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021;42(19):1825–57.CrossRef
16.
go back to reference Leone PP, Regazzoli D, Pagnesi M, et al. TAVI-SMALL investigators. Predictors and clinical impact of prosthesis-patient Mismatch after Self-Expandable TAVR in Small Annuli. JACC Cardiovasc Interv. 2021;14(11):1218–28.CrossRefPubMed Leone PP, Regazzoli D, Pagnesi M, et al. TAVI-SMALL investigators. Predictors and clinical impact of prosthesis-patient Mismatch after Self-Expandable TAVR in Small Annuli. JACC Cardiovasc Interv. 2021;14(11):1218–28.CrossRefPubMed
17.
go back to reference Bhogal S, Rogers T, Waksman R, et al. TAVR in 2023: who should not get it? Am J Cardiol. 2023;193:1–18.CrossRefPubMed Bhogal S, Rogers T, Waksman R, et al. TAVR in 2023: who should not get it? Am J Cardiol. 2023;193:1–18.CrossRefPubMed
18.
go back to reference Rodés-Cabau J, Pibarot P, Leon MB, et al. Impact of aortic annulus size on valve hemodynamics and clinical outcomes after transcatheter and surgical aortic valve replacement: insights from the PARTNER trial. Circ Cardiovasc Interv. 2014;7(5):701–11.CrossRefPubMed Rodés-Cabau J, Pibarot P, Leon MB, et al. Impact of aortic annulus size on valve hemodynamics and clinical outcomes after transcatheter and surgical aortic valve replacement: insights from the PARTNER trial. Circ Cardiovasc Interv. 2014;7(5):701–11.CrossRefPubMed
19.
go back to reference Okuno T, Tomii D, Pilgrim T, et al. 5-Year outcomes with self-expanding vs balloon-expandable transcatheter aortic valve replacement in patients with small Annuli. JACC Cardiovasc Interv. 2023;16(4):429–40.CrossRefPubMed Okuno T, Tomii D, Pilgrim T, et al. 5-Year outcomes with self-expanding vs balloon-expandable transcatheter aortic valve replacement in patients with small Annuli. JACC Cardiovasc Interv. 2023;16(4):429–40.CrossRefPubMed
20.
go back to reference Vahanian A, Beyersdorf F, Praz F, ESC/EACTS Scientific Document Group, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632.CrossRefPubMed Vahanian A, Beyersdorf F, Praz F, ESC/EACTS Scientific Document Group, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632.CrossRefPubMed
21.
go back to reference Kobari Y, Inohara T, Hayashida K, et al. No antithrombotic therapy after transcatheter aortic valve replacement: insight from the OCEAN-TAVI Registry. JACC Cardiovasc Interv. 2023;16(1):79–91.CrossRefPubMed Kobari Y, Inohara T, Hayashida K, et al. No antithrombotic therapy after transcatheter aortic valve replacement: insight from the OCEAN-TAVI Registry. JACC Cardiovasc Interv. 2023;16(1):79–91.CrossRefPubMed
23.
go back to reference Moey MYY, Udani K, hah NN et al. Optimal antiplatelet and antithrombotic regimen post-transcatheter aortic valve replacement. Eur J Clin Invest 2023 Aug 4:e14071. Moey MYY, Udani K, hah NN et al. Optimal antiplatelet and antithrombotic regimen post-transcatheter aortic valve replacement. Eur J Clin Invest 2023 Aug 4:e14071.
24.
go back to reference Abuelazm M, Abdelazeem B, Paul TK, et al. The efficacy and safety of direct oral anticoagulants versus Standard of Care in patients without an indication of anti-coagulants after Transcatheter aortic valve replacement: a Meta-analysis of Randomized controlled trials. J Clin Med. 2022;11(22):6781.CrossRefPubMedPubMedCentral Abuelazm M, Abdelazeem B, Paul TK, et al. The efficacy and safety of direct oral anticoagulants versus Standard of Care in patients without an indication of anti-coagulants after Transcatheter aortic valve replacement: a Meta-analysis of Randomized controlled trials. J Clin Med. 2022;11(22):6781.CrossRefPubMedPubMedCentral
Metadata
Title
Recurrent strokes after transcatheter aortic valve replacement in an elderly patient with severe bicuspid aortic valve stenosis: a case report
Authors
Xuyang Meng
Xiang Wang
Chenguang Yang
Huiping Zhang
You Zhong
Fang Wang
Publication date
20-12-2024

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now